search
Back to results

Procedural Efficiency and Organisational Impact of Rhino Laryngoscopes Procedures in Consults

Primary Purpose

Laryngeal Disease

Status
Recruiting
Phase
Not Applicable
Locations
Denmark
Study Type
Interventional
Intervention
Ambu® aScope™ 4 Rhinolaryngo
Conventional reusable rhinolaryngoscope
Sponsored by
Ambu A/S
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Laryngeal Disease

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • The investigator has been trained and conducted at least 5 successful training procedures with both the aScope 4 RhinoLaryngo and the reusable rhinolaryngoscope systems.
  • The investigator on call for consults must be available to fill out the CRF immediately before and after the procedure.
  • The investigator must be dedicated to the study while on call for consults
  • Clinical indication and eligible for a rhino laryngoscopy, as judged by the physician
  • Patients ≥18 years

Exclusion Criteria:

  • If the patient has no clear indication for rhino laryngoscopy the procedure should not be conducted.

Sites / Locations

  • Ambu A/SRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Rhinolaryngoscope Ambu® aScope™ 4 Rhinolaryngo

Conventional reusable rhinolaryngoscope

Arm Description

All approved procedures performed during the study period.

All procedures performed during the study period.

Outcomes

Primary Outcome Measures

Pre-procedure time from notification of the physician to start of rhinolaryngoscopy.
The time (minutes) from indication of the need for a rhinolaryngoscopy, as registered by the physician until initiation of rhinolaryngoscopy. The mean time registered for the experimental arm will be compared to the active comparator arm to assess differences.

Secondary Outcome Measures

Availability assessed as the time from indication of the need of the rhinolaryngoscopy until the physician leaves to conduct the rhinolaryngoscopy.
Time (minutes) from indication of the need for rhinolaryngoscopy until the investigator leave to conduct the rhinolaryngoscopy. The mean time registered for the experimental arm will be compared to the mean time registered for the active comparator arm to assess differences.
Time from indication for the need of rhinolaryngoscopy until the procedure is completed.
Time from indication for the need of rhinolaryngoscopy until the rhinolaryngoscope has been fully removed from the patient. The outcome will be reported as the area under the curve compared between experimental and active comparator arm.
Organisational impact - User preference for type of rhinolaryngoscope assessment of work process.
User preference assessment of parameters for rhinolaryngoscopy work process (1. Free of wear and tear, 2. Training and education of students, 3. Recording and saving images and videos). Responses rated through 3-point scale - favorable to: 1. Ambu single-use rhinolaryngoscope or 2. conventional reusable rhinolaryngoscope or 3. neutral. Results distributed in percentages.
Organisational impact - User preference for type of rhinolaryngoscope for workflow.
Comparison between workflows for the experimental arm or active comparator. Assessed as the preference of the treating physician through a 3-point scale - favorable to: 1. Ambu single-use rhinolaryngoscope or 2. conventional reusable rhinolaryngoscope or 3. neutral. Results distributed in percentages.
Organisational impact - User evaluation for type of rhinolaryngoscope based on time until start of rhinolaryngoscopy.
User evaluation of which rhinolaryngoscope is expected to have the longest time interval from indication for rhinolaryngoscopy until the start of the procedure, based on previous experience. Response through 3-point scale - favorable to: 1. Ambu single-use rhinolaryngoscope or 2. conventional reusable rhinolaryngoscope or 3. neutral. Results distributed in percentages.
Organisational impact - User preference for type of rhinolaryngoscope based on patient/carer involvement in procedure.
User assessment of which rhinolaryngoscope is the most cumbersome to involve patients or carers in the procedure and subsequent diagnosis or clinical decision (e.g. show or present the procedure and findings during or following the procedure). Response through 3-point scale - favorable to: 1. Ambu single-use rhinolaryngoscope or 2. conventional reusable rhinolaryngoscope or 3. neutral. Results distributed in percentages.
Organisational impact- User preference for type of rhinolaryngoscope based on training requirements and skills.
User preference of training requirement and skills needed from health-care professionals to maneuver rhinolaryngoscope. Response through 3-point scale - favorable to: 1. Ambu single-use rhinolaryngoscope or 2. conventional reusable rhinolaryngoscope or 3. neutral. Results distributed in percentages.
Organisational impact - User preference for type of rhinolaryngoscope based on modes of operation
User preference of which rhinolaryngoscope requires most coordination with colleagues to ensure ready-to-use rhinolaryngoscopes. Response through 3-point scale - favorable to: 1. Ambu single-use rhinolaryngoscope or 2. conventional reusable rhinolaryngoscope or 3. neutral. Results distributed in percentages.
Organisational impact - User preference for type of rhinolaryngoscope based on vigilance and monitoring methods.
User preference of which rhinolaryngoscope requires the least vigilance and monitoring of high hazard or highly infectious diseases. Response through 3-point scale - favorable to: 1. Ambu single-use rhinolaryngoscope or 2. conventional reusable rhinolaryngoscope or 3. neutral. Results distributed in percentages.
Organisational impact - User preference for type of rhinolaryngoscope based on working conditions and safety.
User preference of which rhinolaryngoscope makes the user feel most exposed to infectious agents. Response through 3-point scale - favorable to: 1. Ambu single-use rhinolaryngoscope or 2. conventional reusable rhinolaryngoscope or 3. neutral. Results distributed in percentages.
Organisational impact - Hospital management preference for type of rhinolaryngoscope based on budget allocation.
Hospital management preference for which rhinolaryngoscope requires the least complex budgeting to ensure patient-ready endoscopes and associated technologies. Response through 3-point scale - favorable to: 1. Ambu single-use rhinolaryngoscope or 2. conventional reusable rhinolaryngoscope or 3. neutral. Results distributed in percentages.
Organisational impact - User preference for type of rhinolaryngoscope based on logistics.
User preference of which rhinolaryngoscope is associated with the biggest logistical burden. Response through 3-point scale - favorable to: 1. Ambu single-use rhinolaryngoscope or 2. conventional reusable rhinolaryngoscope or 3. neutral. Results distributed in percentages.
Perception of device
User preference of the image quality, maneuverability, ergonomics of the handle and overall perception of quality of the rhinolaryngoscope will be assessed through a 5-point Likert scale (very poor, poor, acceptable, good or very good).
Intended device
Conversion rate from the rhinolaryngoscope initially intended for the procedure to another rhinolaryngoscope.
Rate of complications
Rate of complications or issues with the rhinolaryngoscope or associated technologies.
Frequency of procedures
Total number of procedures performed per week compared between experimental arm and active comparator.

Full Information

First Posted
November 5, 2021
Last Updated
March 1, 2022
Sponsor
Ambu A/S
Collaborators
Sahlgrenska University Hospital, Sweden, Skane University Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT05198219
Brief Title
Procedural Efficiency and Organisational Impact of Rhino Laryngoscopes Procedures in Consults
Official Title
Procedural Efficiency and Organisational Impact of Rhino Laryngoscopes Procedures in Consults
Study Type
Interventional

2. Study Status

Record Verification Date
March 2022
Overall Recruitment Status
Recruiting
Study Start Date
January 31, 2022 (Actual)
Primary Completion Date
April 30, 2022 (Anticipated)
Study Completion Date
September 1, 2022 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Ambu A/S
Collaborators
Sahlgrenska University Hospital, Sweden, Skane University Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No

5. Study Description

Brief Summary
The aim of this study is to investigate the procedure efficiency, organisational and economic impact, and physician evaluation of the conventional reusable rhino laryngoscope vs. Ambu® aScope™ 4 RhinoLaryngo in procedures conducted distally form the ENT department e.g. in the emergency department (ED), intensive care unit (ICU), ward etc., i.e. consults.
Detailed Description
The aim of this study is to investigate the procedure efficiency, organisational and economic impact, and physician evaluation of the conventional reusable rhinolaryngoscope vs. Ambu® aScope™ 4 RhinoLaryngo in procedures conducted distally from the ENT department e.g. in the emergency department, intensive care unit, ward etc., i.e. consults. The study will be prospective and randomised until 13 procedures have been performed in each group followed by an assessment of the organisational impact and cost comparison of the two technologies. The investigator will track the time and evaluate the device after each procedure. The organisational impact will be accessed by a questionnaire following the study period. A cost comparison will be enabled via tracking all the processes associated with the rhinolaryngoscopes. After tracking all equipment, time, and utilities will be ascribed a cost.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Laryngeal Disease

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
50 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Rhinolaryngoscope Ambu® aScope™ 4 Rhinolaryngo
Arm Type
Experimental
Arm Description
All approved procedures performed during the study period.
Arm Title
Conventional reusable rhinolaryngoscope
Arm Type
Active Comparator
Arm Description
All procedures performed during the study period.
Intervention Type
Device
Intervention Name(s)
Ambu® aScope™ 4 Rhinolaryngo
Intervention Description
Patient indication following a rhinolaryngoscopy
Intervention Type
Device
Intervention Name(s)
Conventional reusable rhinolaryngoscope
Intervention Description
Patient indication following a rhinolaryngoscopy
Primary Outcome Measure Information:
Title
Pre-procedure time from notification of the physician to start of rhinolaryngoscopy.
Description
The time (minutes) from indication of the need for a rhinolaryngoscopy, as registered by the physician until initiation of rhinolaryngoscopy. The mean time registered for the experimental arm will be compared to the active comparator arm to assess differences.
Time Frame
Prior to procedure
Secondary Outcome Measure Information:
Title
Availability assessed as the time from indication of the need of the rhinolaryngoscopy until the physician leaves to conduct the rhinolaryngoscopy.
Description
Time (minutes) from indication of the need for rhinolaryngoscopy until the investigator leave to conduct the rhinolaryngoscopy. The mean time registered for the experimental arm will be compared to the mean time registered for the active comparator arm to assess differences.
Time Frame
Prior to procedure
Title
Time from indication for the need of rhinolaryngoscopy until the procedure is completed.
Description
Time from indication for the need of rhinolaryngoscopy until the rhinolaryngoscope has been fully removed from the patient. The outcome will be reported as the area under the curve compared between experimental and active comparator arm.
Time Frame
Within 24 hours after completion of procedure.
Title
Organisational impact - User preference for type of rhinolaryngoscope assessment of work process.
Description
User preference assessment of parameters for rhinolaryngoscopy work process (1. Free of wear and tear, 2. Training and education of students, 3. Recording and saving images and videos). Responses rated through 3-point scale - favorable to: 1. Ambu single-use rhinolaryngoscope or 2. conventional reusable rhinolaryngoscope or 3. neutral. Results distributed in percentages.
Time Frame
Up to 26 weeks after study completion
Title
Organisational impact - User preference for type of rhinolaryngoscope for workflow.
Description
Comparison between workflows for the experimental arm or active comparator. Assessed as the preference of the treating physician through a 3-point scale - favorable to: 1. Ambu single-use rhinolaryngoscope or 2. conventional reusable rhinolaryngoscope or 3. neutral. Results distributed in percentages.
Time Frame
Up to 26 weeks after study completion
Title
Organisational impact - User evaluation for type of rhinolaryngoscope based on time until start of rhinolaryngoscopy.
Description
User evaluation of which rhinolaryngoscope is expected to have the longest time interval from indication for rhinolaryngoscopy until the start of the procedure, based on previous experience. Response through 3-point scale - favorable to: 1. Ambu single-use rhinolaryngoscope or 2. conventional reusable rhinolaryngoscope or 3. neutral. Results distributed in percentages.
Time Frame
Up to 26 weeks after study completion
Title
Organisational impact - User preference for type of rhinolaryngoscope based on patient/carer involvement in procedure.
Description
User assessment of which rhinolaryngoscope is the most cumbersome to involve patients or carers in the procedure and subsequent diagnosis or clinical decision (e.g. show or present the procedure and findings during or following the procedure). Response through 3-point scale - favorable to: 1. Ambu single-use rhinolaryngoscope or 2. conventional reusable rhinolaryngoscope or 3. neutral. Results distributed in percentages.
Time Frame
Up to 26 weeks after study completion
Title
Organisational impact- User preference for type of rhinolaryngoscope based on training requirements and skills.
Description
User preference of training requirement and skills needed from health-care professionals to maneuver rhinolaryngoscope. Response through 3-point scale - favorable to: 1. Ambu single-use rhinolaryngoscope or 2. conventional reusable rhinolaryngoscope or 3. neutral. Results distributed in percentages.
Time Frame
Up to 26 weeks after study completion
Title
Organisational impact - User preference for type of rhinolaryngoscope based on modes of operation
Description
User preference of which rhinolaryngoscope requires most coordination with colleagues to ensure ready-to-use rhinolaryngoscopes. Response through 3-point scale - favorable to: 1. Ambu single-use rhinolaryngoscope or 2. conventional reusable rhinolaryngoscope or 3. neutral. Results distributed in percentages.
Time Frame
Up to 26 weeks after study completion
Title
Organisational impact - User preference for type of rhinolaryngoscope based on vigilance and monitoring methods.
Description
User preference of which rhinolaryngoscope requires the least vigilance and monitoring of high hazard or highly infectious diseases. Response through 3-point scale - favorable to: 1. Ambu single-use rhinolaryngoscope or 2. conventional reusable rhinolaryngoscope or 3. neutral. Results distributed in percentages.
Time Frame
Up to 26 weeks after study completion
Title
Organisational impact - User preference for type of rhinolaryngoscope based on working conditions and safety.
Description
User preference of which rhinolaryngoscope makes the user feel most exposed to infectious agents. Response through 3-point scale - favorable to: 1. Ambu single-use rhinolaryngoscope or 2. conventional reusable rhinolaryngoscope or 3. neutral. Results distributed in percentages.
Time Frame
Up to 26 weeks after study completion
Title
Organisational impact - Hospital management preference for type of rhinolaryngoscope based on budget allocation.
Description
Hospital management preference for which rhinolaryngoscope requires the least complex budgeting to ensure patient-ready endoscopes and associated technologies. Response through 3-point scale - favorable to: 1. Ambu single-use rhinolaryngoscope or 2. conventional reusable rhinolaryngoscope or 3. neutral. Results distributed in percentages.
Time Frame
Up to 26 weeks after study completion
Title
Organisational impact - User preference for type of rhinolaryngoscope based on logistics.
Description
User preference of which rhinolaryngoscope is associated with the biggest logistical burden. Response through 3-point scale - favorable to: 1. Ambu single-use rhinolaryngoscope or 2. conventional reusable rhinolaryngoscope or 3. neutral. Results distributed in percentages.
Time Frame
Up to 26 weeks after study completion
Title
Perception of device
Description
User preference of the image quality, maneuverability, ergonomics of the handle and overall perception of quality of the rhinolaryngoscope will be assessed through a 5-point Likert scale (very poor, poor, acceptable, good or very good).
Time Frame
During procedure
Title
Intended device
Description
Conversion rate from the rhinolaryngoscope initially intended for the procedure to another rhinolaryngoscope.
Time Frame
During procedure
Title
Rate of complications
Description
Rate of complications or issues with the rhinolaryngoscope or associated technologies.
Time Frame
During procedure
Title
Frequency of procedures
Description
Total number of procedures performed per week compared between experimental arm and active comparator.
Time Frame
Assessed no more than 48 hours after completed week.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: The investigator has been trained and conducted at least 5 successful training procedures with both the aScope 4 RhinoLaryngo and the reusable rhinolaryngoscope systems. The investigator on call for consults must be available to fill out the CRF immediately before and after the procedure. The investigator must be dedicated to the study while on call for consults Clinical indication and eligible for a rhino laryngoscopy, as judged by the physician Patients ≥18 years Exclusion Criteria: If the patient has no clear indication for rhino laryngoscopy the procedure should not be conducted.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Su Zhang, PhD
Phone
+45 20930439
Email
suzh@ambu.com
First Name & Middle Initial & Last Name or Official Title & Degree
Helena Travis, MSc
Phone
+4520679337
Email
hetr@ambu.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Johan Hellgren, MD
Organizational Affiliation
Sahlgrenska Universitetssjukhuset
Official's Role
Principal Investigator
Facility Information:
Facility Name
Ambu A/S
City
Ballerup
State/Province
Hovedstaden
ZIP/Postal Code
2750
Country
Denmark
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Johan Hellgren, MD
First Name & Middle Initial & Last Name & Degree
Cecilia Emanuelsson, MD

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Procedural Efficiency and Organisational Impact of Rhino Laryngoscopes Procedures in Consults

We'll reach out to this number within 24 hrs